Performance of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor (VWF) activity assay on samples from patients receiving DDAVP or VWF concentrates

被引：0
|
作者：
Nardi, M. A. [1 ]
机构：
[1] NYU, Sch Med, New York, NY USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2014年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
VWF21
引用
下载
收藏
页码：97 / 97
页数：1
相关论文
共 14 条
  • [1] Validation of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor activity assay
    Chen, D.
    Tange, J. I.
    Meyers, B. J.
    Pruthi, R. K.
    Nichols, W. L.
    Heit, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (10) : 1993 - 2002
  • [2] Analytical Performance of a New Immunoturbidimetric Assay for von Willebrand Factor (VWF) Activity Testing
    Louw, Susan
    Wan, Yuen O.
    Mayne, Elizabeth S.
    Mahlangu, Johnny N.
    CLINICAL LABORATORY, 2019, 65 (04) : 659 - 662
  • [3] Evaluation of a rapid von Willebrand Factor Activity Latex Immuno Assay for monitoring of patients with von Willebrand disease (VWD) receiving DDAVP® or VWF replacement therapy
    Vinayagam, S.
    Simons, L. R.
    Chowdary, P.
    Thurlow, P.
    Brooks, S. V.
    Riddell, A. F.
    HAEMOPHILIA, 2014, 20 (04) : e304 - e310
  • [4] Laboratory characteristics of an automated von Willebrand factor activity (VWF) assay
    Tange, J., I
    Chen, D.
    Pruthi, R. K.
    Nichols, W. L.
    Heit, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 533 - 533
  • [5] Detection of Continuous Flow Left Ventricular Assist Device -Associated Acquired Von Willebrand Factor (VWF) Abnormality by An Automated Immunoturbidimetric VWF Activity Assay
    He, Rong
    Crow, Sheri
    Joyce, Lyle D.
    Milano, Carmelo
    Heit, John A.
    Chen, Dong
    BLOOD, 2011, 118 (21) : 987 - 987
  • [6] Evaluation of an automated latex particle method (HemosIL™ VWF Activity) for the measurement of VWF activity in patients receiving treatment
    Vinayagam, S.
    Brooks, S.
    Riddell, A.
    Chowdary, P.
    HAEMOPHILIA, 2008, 14 : 25 - 25
  • [7] Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method
    Hillarp, A.
    Friedman, K. D.
    Adcock-Funk, D.
    Tiefenbacher, S.
    Nichols, W. L.
    Chen, D.
    Stadler, M.
    Schwartz, B. A.
    HAEMOPHILIA, 2015, 21 (06) : 837 - 845
  • [8] Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay (VWF:RCo) using a novel automated assay protocol
    Hillarp, A.
    Stadler, M.
    Haderer, C.
    Weinberger, J.
    Kessler, C.
    Roemisch, J.
    Schwartz, B.
    HAEMOPHILIA, 2011, 17 (03) : 560 - 560
  • [9] Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay (VWF:RCo) using a novel automated assay protocol
    Hillarp, A.
    Stadler, M.
    Haderer, C.
    Weinberger, J.
    Kessler, C.
    Roemisch, J.
    HAEMOPHILIA, 2010, 16 : 150 - 150
  • [10] Monitoring von Willebrand factor replacement therapy in the setting of orthotopic liver transplantation using a rapid latex VWF activity assay
    Brooks, S., V
    Lanning, L.
    Unadkat, S.
    Condez, A.
    O'Beirne, J.
    Gatt, A.
    Chowdary, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 846 - 846
12